
    
      This is a non-controlled, open-label, 4 weeks pilot study.

      As the main goal of this exploratory study is the estimation of the magnitude of the Left
      Atrial /Left Atrial Appendage thrombus resolution with edoxaban, no control group with
      vitamin K antagonists has been considered, providing that, for the purpose of this study, the
      magnitude of the response of warfarin is satisfactory defined.
    
  